| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/22/2009 | US7592372 Mixture of fudostein, acid and sweetening |
| 09/22/2009 | US7592307 Releasable linkage and compositions containing same |
| 09/22/2009 | US7592300 Skin cleaning compounds, body splash, surgical scrub, wound care agents, hand sanitizers, disinfectants, mouthwashes, pet shampoos, hard surface sanitizer; reduction of bacteria, rotavirus, or rhinovirus on skin surface; topical |
| 09/22/2009 | US7592021 Bioadhesive delivery system for transmucosal delivery of beneficial agents |
| 09/22/2009 | US7592020 Personal care products with visual indicator of vaginitis |
| 09/22/2009 | US7592019 Suitable in particular for the care and/or cleansing of the skin |
| 09/22/2009 | US7592018 A soft, pliable, dissolvable candy,(Gummi-Bears) having an oval shape where a plurality of hard segments-like ridges are formed on a surface of the soft candy which afford an abrasive scraping action on the tongue as the candy is eaten; covering power; cleaning compounds; denistry |
| 09/22/2009 | US7592016 Methods for preparing and using implantable substance delivery devices |
| 09/22/2009 | US7592004 Lyophilizing an aqueous formulation comprising a high concentration, 50 mg/ml or more of an immunoglobulin IgG antibody, in particular, daclizumab, in 5-25 mM histidine buffer, having pH 5.5-6.5, 0.005%-0.03% polysorbate, and sucrose |
| 09/22/2009 | US7591999 An active material, a nonwater-absorbant, hardly water-soluble cellulose and a mucolytic cysteine derivative; aqueous ethanol/insulin solution, ethyl cellulose, N-acetylcysteine; inproved absorption, permeability of the physiologically active substance at a nasal mucous membrane; side effect reduction |
| 09/22/2009 | US7591993 Microspheres useful for embolization which comprises polyvinylalcohol. The present invention also relates to an injectable suspension suitable for embolization which comprises the polyvinylalcohol microspheres and a suitable |
| 09/22/2009 | US7591949 Method for the improvement of transport across adaptable semi-permeable barriers |
| 09/22/2009 | US7591806 High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances |
| 09/22/2009 | CA2558916C Method to fabricate microcapsules from polymers and charged nanoparticles |
| 09/22/2009 | CA2487940C Ophthalmic drug delivery system |
| 09/22/2009 | CA2432534C Gel composition and trans-scrotal application of a composition for the treatment of hypogonadism |
| 09/22/2009 | CA2426349C Over-coated chewing gum formulations including tableted center |
| 09/22/2009 | CA2402121C Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 09/22/2009 | CA2399451C Tyrosine derivatives with anti-leukotriene activity |
| 09/22/2009 | CA2395709C Process for the preparation of micronised collagen, and its therapeutic applications |
| 09/22/2009 | CA2353604C Polymeric coatings for controlled delivery of active agents |
| 09/22/2009 | CA2331284C Solution comprising prostaglandins and benzyl alcohol |
| 09/22/2009 | CA2110370C Stabilized pulverulent active agents, compositions containing them, process for obtaining them and their applications |
| 09/17/2009 | WO2009114773A2 Modified release formulations of anti-irritability drugs |
| 09/17/2009 | WO2009114745A1 Formulations of vitamin k analogs for topical use |
| 09/17/2009 | WO2009114719A2 Apparatus and method of retaining and releasing molecules from nanostructures by an external stimulus |
| 09/17/2009 | WO2009114695A1 Nanoparticulate compositions of angiogenesis inhibitors |
| 09/17/2009 | WO2009114685A2 O-desmethylvenlafaxine salts |
| 09/17/2009 | WO2009114648A1 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
| 09/17/2009 | WO2009114614A2 Compositions and methods for controlled delivery of inhibitory ribonucleic acids |
| 09/17/2009 | WO2009114606A1 Drug delivery systems comprising weakly basic drugs and organic acids |
| 09/17/2009 | WO2009114521A1 Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection |
| 09/17/2009 | WO2009114491A1 Compressed tablets |
| 09/17/2009 | WO2009114368A2 Activated nitric oxide donors and methods of making and using thereof |
| 09/17/2009 | WO2009114227A1 Use of magnesium stearate dihydrate for lubrication of solid industrial or consumer products |
| 09/17/2009 | WO2009114226A1 Use of magnesium stearate dihydrate for lubrication of solid pharmaceutical compositions |
| 09/17/2009 | WO2009114192A2 Enhanced transmucosal composition and dosage form |
| 09/17/2009 | WO2009113910A1 Antiinflammatory and antiallergic gel |
| 09/17/2009 | WO2009113703A2 Orally-disintegrating solid preparation |
| 09/17/2009 | WO2009113578A1 Carbonyl compound remover |
| 09/17/2009 | WO2009113522A1 Solid dispersion, pharmaceutical compositions containing the same, and processes for the production of both |
| 09/17/2009 | WO2009113504A1 Patch |
| 09/17/2009 | WO2009113420A1 Improvement of dissolvability of preparation containing olmesartan medoxomil |
| 09/17/2009 | WO2009113091A2 Pharmaceutical compositions comprising valsartan |
| 09/17/2009 | WO2009113090A2 Process for preparing an oral formulation of an acid-sensitive benzimidazole drug |
| 09/17/2009 | WO2009113086A2 Ibuprofen liquid fill formulation, dosage form thereof and a process for its preparation |
| 09/17/2009 | WO2009113061A1 Humidity-resistant drug formulations and methods of preparation thereof |
| 09/17/2009 | WO2009113051A2 Oral modified-release formulations containing thiazepines |
| 09/17/2009 | WO2009112878A1 Drug delivery to the anterior and posterior segments of the eye using eye drops. |
| 09/17/2009 | WO2009112874A1 Modified release composition comprising doxofylline |
| 09/17/2009 | WO2009112870A1 Pharmaceutical composition comprising rosuvastatin calcium and magnesium carbonate hydroxide pentahydrate as a stabilizer |
| 09/17/2009 | WO2009112800A1 Losartan composition |
| 09/17/2009 | WO2009112769A2 Pharmaceutical dye extracted from cranberry with high proanthocyanidin a concentration |
| 09/17/2009 | WO2009112740A2 Large particle size crystallised maltitol powder, method for preparing same and applications thereof, particularly in chocolate production |
| 09/17/2009 | WO2009112682A1 Encapsulation of vitamin c into water soluble dendrimers |
| 09/17/2009 | WO2009112493A1 Formulation and method for the prevention and treatment of bone metastases or other bone diseases |
| 09/17/2009 | WO2009112436A1 Modified release composition comprising doxofylline |
| 09/17/2009 | WO2009112287A1 Process and apparatus for producing a tabletting aid and also a tabletting aid and tabletting mixture |
| 09/17/2009 | WO2009112274A2 Novel dosage and formulation |
| 09/17/2009 | WO2009112273A2 Novel dosage and formulation |
| 09/17/2009 | WO2009112258A1 Long-term stable pharmaceutical preparation having the active ingredient glycerol trinitrate |
| 09/17/2009 | WO2009112169A2 Suspension formula for carbon adsorbents |
| 09/17/2009 | WO2009112167A1 Transdermal therapeutic system having stabilized membrane |
| 09/17/2009 | WO2009112156A1 Palatable solid composition comprising antacid and saliva stimulant |
| 09/17/2009 | WO2009112054A1 High bioavailability formulation of mangosteen and manufacturing process thereof |
| 09/17/2009 | WO2009111852A2 Process to obtain a pharmaceutical composition of retinoids, derivative product of retinoids and its use |
| 09/17/2009 | WO2009089338A3 Method and compositions for administering resveratrol and pterostilbene |
| 09/17/2009 | WO2009089070A9 Compositions and methods for reducing particle penetration through mucus |
| 09/17/2009 | WO2009087657A3 Stable pharmaceutical composition of duloxetine and process for its preparation |
| 09/17/2009 | WO2009087410A3 Solid pharmaceutical dosage form |
| 09/17/2009 | WO2009085766A3 Fenofibric acid amorphous dispersion; method of making; and method of use thereof |
| 09/17/2009 | WO2009084069A3 Ocular solution with organic lycopene |
| 09/17/2009 | WO2009071850A8 Nanoparticles of therapeutic agents having low water solubility |
| 09/17/2009 | WO2009052491A3 Fenoldopam formulations and prodrug derivatives |
| 09/17/2009 | WO2009024992A3 Film coating compositions based on tribasic calcium phosphate |
| 09/17/2009 | WO2009006130A3 Salt free hyaluronate ophthalmic solution |
| 09/17/2009 | WO2008148733A3 Pharmaceutical formulation for the production of rapidly disintegrating tablets |
| 09/17/2009 | WO2008116636A3 Therapeutic plaster for trigger and acupuncture points and for meridian therapy |
| 09/17/2009 | WO2008101179A8 Use of sucrose to suppress mannitol-induced protein aggregation |
| 09/17/2009 | WO2006078979A9 Vectors and methods for genetic immunization |
| 09/17/2009 | US20090234331 Electronically controlled pill and system having at least one sensor for delivering at least one medicament |
| 09/17/2009 | US20090234271 COMPOSITION COMPRISING siRNA-POLYCATION COMPLEX FOR IONTOPHORESIS |
| 09/17/2009 | US20090232901 Polymeric microspheres |
| 09/17/2009 | US20090232900 Nano-micellar preparation of anthracylcline antitumor antibiotics encapsulated by the phosphatide derivatized with polyethylene glycol |
| 09/17/2009 | US20090232899 Mucoadhesive nanocomposite delivery system |
| 09/17/2009 | US20090232898 Pharmaceutical Compositions Useful in the Treatment of Migraine |
| 09/17/2009 | US20090232897 Pharmaceutical compositions comprising conjugated estrogens |
| 09/17/2009 | US20090232896 Use of Magnesium Stearate Dihydrate for Lubrication of Solid Pharmaceutical Compositions |
| 09/17/2009 | US20090232895 Procedure and devices for the controlled obtaining of dry saline aerosols with therapeutic effect |
| 09/17/2009 | US20090232894 Process for Stabilizing an Adjuvant Containing Vaccine Composition |
| 09/17/2009 | US20090232893 miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
| 09/17/2009 | US20090232892 Cellooligosaccharide-Containing Composition |
| 09/17/2009 | US20090232891 Cell Transport Compositions and Uses Thereof |
| 09/17/2009 | US20090232890 Compositions and methods for distraction osteogenesis |
| 09/17/2009 | US20090232889 Crystalline salts of quinoline compounds and methods for preparing them |
| 09/17/2009 | US20090232888 Sustained delivery of antibiotics |
| 09/17/2009 | US20090232887 Pharmaceutical composition having reduced abuse potential |
| 09/17/2009 | US20090232886 Oral dosage combination pharmaceutical packaging |
| 09/17/2009 | US20090232885 Drug Delivery Systems Comprising Weakly Basic Drugs and Organic Acids |
| 09/17/2009 | US20090232884 Composition and method for treatment of the side-effects associated with administration of cancer chemotherapeutic agents |